Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs

PURPOSE: To evaluate the efficacy of switching to aflibercept in diabetic macular edema (DME) with suboptimal response to previous anti-vascular endothelial growth factor (anti-VEGF) injections. METHODS: A prospective interventional case series study recruited patients from a single center diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Walid S., Eldaly, Zeiad H., Saleh, Mohamed G., Rateb, Mahmoud F., Aldoghaimy, Ahmed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462479/
https://www.ncbi.nlm.nih.gov/pubmed/30977321
http://dx.doi.org/10.3341/kjo.2018.0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462479/
https://www.ncbi.nlm.nih.gov/pubmed/30977321
http://dx.doi.org/10.3341/kjo.2018.0037

Ejemplares similares